Lack of cancer test costs Ontario mil...

Lack of cancer test costs Ontario millions

There are 2 comments on the The Globe and Mail story from Jul 4, 2008, titled Lack of cancer test costs Ontario millions. In it, The Globe and Mail reports that:

Some Canadian patients are needlessly being sent to the United States to receive one of the world's most costly cancer drugs, largely because a test that can reveal whether the medicine would be futile is ...

Join the discussion below, or Read more at The Globe and Mail.

Since: Dec 05

Irvington, NJ

#1 Jul 4, 2008
For decades, scientists have been trying to get around the drug resistance that is characteristic of all cancers. Some say, not a single drug or combination of drugs has succeeded.

The assumption behind all the efforts has been the gene mutation theory of cancer. Mutated genes somehow either cause cancer directly or inactivate genes thought to guard against cancer, the so-called oncogenes (mutations involving the oncogene k-Ras) and tumor suppressor genes. However, there is no functional proof that the gene mutation theory is correct.

The gene mutation theory of cancer hasn’t yet produced the types of breakthroughs we all want. Everyone in cancer research seems to have centered their attention on gene being the culprit. It would be expected that after more than a century of pursuing this one angle, and the numerous links that have been made, this should have lead to more progress than is presently observed.

Sequencing the genome of cancer cells is explicitly based upon the assumption that the pathways of tumor cells can be known in sufficient detail to control cancer, an assumption that some scientists believe to be false. The assumption that the pathways of tumor cells can be known in a patient with metastatic cancer is logically inconsistent with the reality of tumor cell evolution.

The target of Erbitux (cetuximib), EGFR was found to be absent in 35% of metastatic lesions even though the primary tumor was EGFR positive. In other words, tumor cells evolved in the patients that lacked the drug's target.

The problem is that a patient with metastatic cancer can have billions of unknown cancer cells disseminated throughout the body at unknown locations. Each cancer cell can be different. And the cancer cells that are present change and evolve with time.

There is another effort in research called the chromosomal theory of cancer. Even if cancers are from the same tissue, and are generated with the same carcinogen, they are never the same. There is always a cytogenetic and a biochemical individuality in every cancer.
#2 Sep 23, 2013
I have ordered 2 times from this website PILLSMEDSHOP. COM . I called yesterday the customer care and asked for a discount as i was about to order twice the regular amount.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Oncology Discussions

Title Updated Last By Comments
News Microsoft wants to 'solve cancer' with computer... Sep 20 Stephany McDowell 2
News Cancer-risk genetic testing reports can vary fr... Sep 16 Stephany McDowell 1
News Retired Ringling Bros. circus elephants have a ... Sep 16 Stephany McDowell 1
News Want a Brca Test? Some Insurers Require Genetic... Sep 14 Stephany McDowell 3
News Inheriting a Greater Risk of Cancer Sep 10 Stephany McDowell 1
News Cancer "Moon Shot" Plans Should Include Tumor P... Sep 8 Stephany McDowell 1
Pancreatic cancer Sep 5 STEPH LYNCH 1
More from around the web